... < 0.01). In 4-week-old FHL and FHH, plasma cholesterol levels were similar. Subsequently, cholesterol increased in FHH, reaching 3.4 ± 0.9 mmol/l at 40 weeks, whereas cholesterol was barely affected by aging in FHL (2.1 ± 0.2 mmol/l at 40 weeks). At 4 weeks, triglyceride levels were lowest in FHH...

...Margret Arnadottir; Lars-Olof Eriksson; John I. Germershausen; Hans Thysell The high prevalence of hypercholesterolemia in kidney transplant recipients probably contributes to the high cardiovascular mortality in these patients. Except for diet, there is no generally recommended cholesterol...

...T.M. Chan; I.K.P. Cheng; S.C.F. Tam Thirty-eight renal allograft recipients who had persistent hyperlipidemia and stable renal function 27.8 ± 18.2 months after renal transplantation were treated with gemfibrozil. Gemfibrozil therapy resulted in a decrease in the levels of total cholesterol (TC...

... unknown. Mevalonate is the direct product of the rate-limiting step in cholesterol synthesis which is catalyzed by 3-hydroxy-3-methylglutaryl coenzyme A reductase. We studied the changes in mevalonate metabolism in a mouse model of CRF in which serum total cholesterol levels are directly correlated...

...) with stable renal function (mean plasma creatinine 0.14 mmol/l, SD 0.07), 7 months to 21 years after renal transplantation. Fifteen patients (24%) were above the age- and sex-adjusted 95th percentile for total triglyceride and 10 (16%) for total cholesterol concentrations when compared with a local reference...

...Kenneth A. Schneider; Siegfried Heyden; Charles Ford The recent experience of six large trials of antihypertensive therapy has not clearly demonstrated any beneficial effect on the prevention of coronary heart disease (CHD). The data from the HDFP study have been analyzed by three cholesterol...

... significantly higher in uremic rats than in control animals of both groups. In addition to triglycerides, serum total cholesterol and phospholipids were also increased in uremic rats. The fractional clearance rate of Intralipid® [K2(%)] was decreased in uremic as compared to control animals. The in vivo...

...J. Joven; J. Rubiés-Prat; E. Espinel; P. Chacón; A. Olmos; S. Masdeu Serum concentration of apoprotein A-I (apo A-I) and cholesterol content in high density lipoprotein (HDL) subfractions have been studied in 19 men and 11 women at the end stage of chronic renal failure undergoing hemodialysis. HDL...

...Pierre C. Bories; Papasani V. Subbaiah; John D. Bagdade Lecithin cholesterol acyltransferase (LCAT) and lysolecithin acyltransferase (LAT) activities in plasma were significantly lower in undialyzed than in dialyzed uremic patients and controls. Both LCAT and LAT activities were normal...

...J. Rubiés-Prat; R. Romero; P. Chacón; S. Masdeu; J. Griño; A. Caralps Serum concentrations of high density lipoproteins (HDL)-cholesterol, apoprotein A and apoprotein B has been studied in 13 patients with chronic renal failure treated with hemodialysis and in 12 patients with functioning renal...

... to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Red blood cell Deformability Renal failure Diabetic nephropathy Cholesterol BUN Creatinine HbAic Nephron 30: 8-14 (1982) Red Blood Cell Deformability in Renal...

...J.M. Ramos; A. Heaton; J.G. McGurk; M.K. Ward; D.N.S. Kerr Serum cholesterol, triglycerides and their fractions in high density (HDL), low density (LDL) and very low density (VLDL) lipoproteins were measured sequentially in fasting patients on continuous ambulatory peritoneal dialysis (CAPD) who...

...L.B. Haas; P.W. Wahl; D.J. Sherrard From this study of 163 males and 57 females on maintenance dialysis, evidence is presented that lipid levels, except for cholesterol in females, remain stable for the first 5 years. Thus, baseline lipid classifications are valid through this time period. 3...

... weeks of uremia. During the last 7 weeks the rabbits were fed an individually adjusted amount of cholesterol in order to maintain the same elevated level of plasma cholesterol in both groups. The triglyceride concentration was four times higher in the uremic than in the control group. In spite...

... < 0.01), serum cholesterol (p < 0.01), erythrocyte sedimentation rate (p < 0.02), and a significant reduction in the albumin/fibrinogen ratio (p < 0.005) when compared with those free of disease. Two patients with no apparent vascular disease when investigated were found to have distinctly...

... increases in RBC folate and an average decrease in plasma Hcy concentration of 33%. Mean total cholesterol, LDL cholesterol and triglyceride concentrations decreased significantly in the CAPD patients who took folate. Folate had no significant effect on hemorheology. In conclusion, folate supplements...

... ± 0.39 vs. ARAS 1.24 ± 0.28; mean ± SD), cholesterol (control 5.65 ± 1.28 vs. ARAS 6.12 ± 1.29), LDL cholesterol (control 3.72 ± 1.03 vs. ARAS 4.06 ± 1.18), fibrinogen (control 2.48 ± 1.39 vs. ARAS 3.29 ± 1.49), HDL cholesterol (control 1.16 ± 0.38 vs. ARAS 1.00 ± 0.26) and triglyceride (control 1.68...